Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences Inc. (RKDA)
Market is closed
Sector: Agricultural Production-Crops
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.49 | 700 | 2,681 | 2025-02-03 | Filing | ||
| $2.49 | 700 | 2,819 | 2025-02-03 | Filing | ||
| $2.06 | 700 | 1,981 | 2024-08-01 | Filing | ||
| $2.06 | 700 | 2,119 | 2024-08-01 | Filing | ||
| $2.06 | 700 | 1,419 | 2024-02-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.44 | 5,000 | Director | 7,335 | 2018-03-23 | Filing | |
| $32.74 | 1,750 | Officer | 558 | 2018-03-23 | Filing | |
| $60.00 | 250 | Director | 7,335 | 2018-03-15 | Filing | |
| $45.21 | 21,005 | Director | 7,335 | 2018-03-14 | Filing | |
| $0.23 | 5,950 | Officer | 11,153 | 2017-11-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,000 | $148,000 | 0% | |
| 2. | 14,038 | $83,105 | 0% | |
| 3. | 13,945 | $82,554 | 0% | |
| 4. | 12,297 | $72,798 | 0% | |
| 5. | 12,146 | $71,904 | 0% |
News See All
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2024 Financial Results and Business Highlights Conference Call. At this time all, participants are in a listen-only mode.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Arcadia Biosciences Second Quarter 2024 Financial Result and Business Highlight Conference Call. At this time all participants are in a listen-only mode.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2024 Earnings Call Transcript
Arcadia Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.78, expectations were $-2.52.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Arcadia Biosciences Fourth Quarter and Full Year 2023 Financial Results and Business Highlights Conference Call.
13 Most Advanced Countries in Agriculture Technology
In this article, we discuss the 13 most advanced countries in agriculture technology.
5 Most Advanced Countries in Agriculture Technology
In this article, we discuss the 5 most advanced countries in agriculture technology.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to Arcadia Biosciences Third Quarter 2023 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Arcadia Biosciences' Second Quarter 2023 Financial Results and Business Highlights Conference Call. At this time, all participants are in a listen-only mode.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Arcadia Biosciences' First Quarter 2023 Financial Results and Business Highlights Conference Call. At this time all participants are in a listen-only mode.
Billionaire Hedge Funds
